CLEVELAND, OH–(Marketwired – June 03, 2015) – Ganeden Biotech, the makers of the patented probiotic GanedenBC30, today announced that new data showing the improvement of five protein utilization end points will be presented by Dr. Ralf Jäger, FISSN, CISSN, MBA at the 12th Annual International Society of Sports Nutrition (ISSN) conference, taking place June 11-13 in Austin, TX.
The presentation, titled “Probiotics Flex Their Muscles in Sports Nutrition: the Gut‐Muscle‐Axis” is scheduled for Saturday, June 13th from 2:00-2:50pm and is based on a study conducted by the University of Tampa and Increnovo LLC, which found that GanedenBC30 supports protein utilization as measured by a reduction of muscle soreness and increased perceived recovery.
“In our study, co-administration of GanedenBC30 with protein was able to protect the muscle from damage as shown by perceptual measures and blood work, resulting in faster recovery and most importantly, in increased performance,” said Dr. Ralf Jäger. “This is a true game changer in the world of probiotic research in sports; as this is the first study of a probiotic showing ergogenic effects in athletes.”
For conference details or to download the full program please visit SportsNutritionSociety.org.
Also, catch Dr. Ralf Jäger presenting brand new, additional data on this topic a Probiotia Americas (San Diego CA) on June 5 at 9:30am and at IFT (Chicago IL) on July 14 at 11:00am in booth 3887. More details to come!
About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30 (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden’s newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit GanedenBiotech.com.
Introducing GanedenBC30® (Bacillus coagulans GBI-30, 6086), Ganeden Biotech’s patented probiotic ingredient that can be found in more than 150 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains, GanedenBC30 is a spore-forming organism which makes it highly stable and allows it to remain viable through most manufacturing processes, three years of shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 21 published studies showing digestive and immune support and GanedenBC30 has an exceptional safety record with FDA GRAS status from the United States FDA. It can be formulated into virtually any food, beverage and companion animal product that experiences high or low temperature, pressure or environmental extremes including all hot or refrigerated beverages! For more information, please visit GanedenBiotech.com or GanedenBC30.com.